Daniel Apel

Daniel Apel

Director of Finance/CFO at ARROWHEAD PHARMACEUTICALS, INC.

Net worth: 11 M $ as of 27/02/2026

Health Technology
Consumer Services
Commercial Services

Profile

Daniel J.
Apel
is currently Director at Conceptus, Inc. since 2013, Director at Biotechnology Innovation Organization, and Chief Financial Officer at Arrowhead Pharmaceuticals, Inc. starting in 2025.
Formerly, Mr. Apel was Chief Financial Officer at Bayer Corp.
from 2016 to 2019 and Global Head-Financial Planning & Analysis at Walgreens Boots Alliance, Inc. from 2019 to 2024.
Education includes undergraduate studies at the University of Pennsylvania and an MBA from the University of California, Berkeley.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
05/01/2026 176,200 ( 0.13% ) 11 M $ 27/02/2026

Daniel Apel active positions

CompaniesPositionStart
ARROWHEAD PHARMACEUTICALS, INC. Director of Finance/CFO 12/05/2025
Director/Board Member -
Director/Board Member 04/06/2013

Former positions of Daniel Apel

CompaniesPositionEnd
WALGREENS BOOTS ALLIANCE, INC. Corporate Officer/Principal 31/12/2023
Director of Finance/CFO 31/12/2018
See the detail of Daniel Apel's experience

Training of Daniel Apel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

68

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Retail Trade

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW